Furthermore, when BEVs were administered to the intestinal flora of obese mice, insulin-stimulated p-AKT levels significantly decreased, insulin resistance worsened, and the progression of MAFLD was promoted (Luo et al., 2021; Luo et al., 2022). Here, AKT1 is linked to Insulin resistance.